Study to verify the effect of sleep quality improvement effect and nighttime blood glucose level change by using 4-layer special three-dimensional mattress

Not Applicable

• Conditions: Healthy volunteer

• Registration Number: JPRN-UMIN000031144
• Lead Sponsor: Anti-Aging Bank Co.,Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-09
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Not provided

Exclusion Criteria

[1]Individuals using medical products [2]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [3]Individuals who are suspected, recived treatment of, or have a history of sleep apnea syndrome [4]Individuals who have or are suspected with the night urination, prostatomegaly, or overactive bladder [5]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. [6]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [7]Individuals with history of gastrointestinal disorders except for appendicitis [8]Individuals with >=25.0kg/m2 BMI [9]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [10]Individuals who have experienced mood disorder or condition deterioration due to blood sampling in the past [11]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [12]Individuals who have the possibility of developing seasonal allergic symptoms such as hay fever and the possibility of using medicines (eyedrops, nose drops are acceptable) [13]Individuals who continuously ingest supplements that have effects on blood glucose levels and supplements that contain vitamin C and those who intend to consume during the study period (but not those who can stop taking the intake at the time of consent acquisition) [14]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [15]Individuals whose life style will change during the test period (ex. travel for a long time) [16]Individuals who are or are posslibly, or are lactating [17]Individuals with a scheduled or likely to visit an MRI examination during the period of this study etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ight of the blood glucose level,AUC

Secondary Outcome Measures

Name	Time	Method
[1]Sleep-related hormone test (Week 0, Week 2) [2] OSA sleep inventory MA version (Week 0, Week 2) [3]Japanese version of the Pittsburgh Sleep Quality Index (Week 0, Week 2)